{"id":"https://openalex.org/W4415899216","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0973","title":"973 Identification of MUC13xMSLN as a novel tumor-specific antigen pair for AND-gated T cell engagers in colorectal cancer","display_name":"973 Identification of MUC13xMSLN as a novel tumor-specific antigen pair for AND-gated T cell engagers in colorectal cancer","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4415899216","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0973"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0973","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0973","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0973","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A1101.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/13/Suppl_2/A1101.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Catherine C Henry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine C Henry","raw_affiliation_strings":["Cullinan Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cullinan Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007202196","display_name":"Kavya Rakhra","orcid":"https://orcid.org/0000-0003-2371-0470","observed_orcids":["https://orcid.org/0000-0003-2371-0470"]},"institutions":[{"id":"https://openalex.org/I4394709232","display_name":"Cullinan Oncology (United States)","ror":"https://ror.org/012n0t549","country_code":"US","type":"company","lineage":["https://openalex.org/I4394709232"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kavya Rakhra","raw_affiliation_strings":["Cullinan Oncology, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cullinan Oncology, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I4394709232"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058901224","display_name":"Patrick A. Baeuerle","orcid":"https://orcid.org/0009-0006-7117-2784","observed_orcids":["https://orcid.org/0009-0006-7117-2784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick A Baeuerle","raw_affiliation_strings":["Cullinan Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cullinan Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025104951","display_name":"Jennifer S. Michaelson","orcid":"https://orcid.org/0009-0005-4539-460X","observed_orcids":["https://orcid.org/0009-0005-4539-460X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer S Michaelson","raw_affiliation_strings":["Cullinan Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cullinan Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082196069","display_name":"Karsten Sauer","orcid":"https://orcid.org/0000-0002-8355-9429","observed_orcids":["https://orcid.org/0000-0002-8355-9429"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karsten Sauer","raw_affiliation_strings":["Cullinan Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cullinan Therapeutics, Cambridge, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1101","last_page":"A1101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.38350000977516174,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.38350000977516174,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.3481000065803528,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.09200000017881393,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/muc13","display_name":"MUC13","score":0.9010000228881836},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.9430000185966492},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.847000002861023},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6869999766349792},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.6639999747276306},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.33399999141693115},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.49900001287460327},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.4339999854564667},{"id":"https://openalex.org/keywords/tumor-associated-neutrophils","display_name":"tumor-associated neutrophils","score":0.6190000176429749},{"id":"https://openalex.org/keywords/tumor-associated-t-cells","display_name":"tumor-associated T cells","score":0.4050000011920929},{"id":"https://openalex.org/keywords/tumor-associated-b-cells","display_name":"tumor-associated B cells","score":0.42399999499320984},{"id":"https://openalex.org/keywords/tumor-associated-nk-cells","display_name":"tumor-associated NK cells","score":0.3919999897480011},{"id":"https://openalex.org/keywords/tumor-associated-dendritic-cells","display_name":"tumor-associated dendritic cells","score":0.5},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.5989999771118164},{"id":"https://openalex.org/keywords/tumor-associated-endothelial-cells","display_name":"tumor endothelial cells","score":0.49399998784065247},{"id":"https://openalex.org/keywords/tumor-associated-myeloid-cells","display_name":"tumor-associated myeloid cells","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.6101999878883362},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5902000069618225},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.4997999966144562},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4551999866962433},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.45320001244544983},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3578999936580658},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3386000096797943},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3353999853134155},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3312999904155731},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2881999909877777},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2750000059604645},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.265500009059906},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.2639999985694885},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.25519999861717224},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25459998846054077},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.25279998779296875}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2025-sitc2025.0973","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0973","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0973","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A1101.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0973","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0973","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0973","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A1101.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415899216.pdf","grobid_xml":"https://content.openalex.org/works/W4415899216.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404064125","https://openalex.org/W7148997465","https://openalex.org/W4409624326","https://openalex.org/W4409632405","https://openalex.org/W4380146434","https://openalex.org/W3112202821","https://openalex.org/W4296115095","https://openalex.org/W7208717959","https://openalex.org/W3084569243","https://openalex.org/W4309739662"],"abstract_inverted_index":{"Background":[0],"T":[1,536,615,648,661],"cell":[2,108,118,421,449,537,566,581,616,620],"engagers":[3],"(TCEs)":[4],"are":[5,43,54],"powerful":[6],"therapeutics":[7],"which":[8,53],"can":[9,73],"kill":[10],"cells":[11,47,103,311,359,662],"expressing":[12,349],"low":[13,250],"levels":[14,251],"of":[15,51,231,241,252,268,273,286,291,309,312,324,347,356,429,440,467,497,512,530,569,598,639,659],"target":[16,351],"antigen.":[17],"To":[18,135,316],"limit":[19],"on-target":[20],"off-tumor":[21],"toxicity,":[22],"it":[23],"is":[24,320,363,377],"critical":[25],"to":[26,83,100,131,229,584],"identify":[27,84,101],"antigens":[28,42,52],"with":[29,77,184,279,341],"limited":[30],"normal":[31,58,151,171,248],"tissue":[32,152,182,195,297],"expression":[33,153,188,230,510],"or":[34],"apply":[35],"strategies":[36],"for":[37,91,112,150,222,255,299,379,382,549],"conditional":[38],"engagement.":[39],"While":[40],"few":[41],"completely":[44],"tumor-specific,":[45],"tumor":[46,102,173,203,420,441],"may":[48,337],"co-express":[49],"pairs":[50,65,205],"not":[55,67],"co-expressed":[56,137,202],"on":[57,170],"cells.":[59,649],"By":[60],"selectively":[61],"targeting":[62,243,668],"such":[63],"antigen":[64,89,204,532,666],"but":[66],"the":[68,232,280,321,345,350,354,370,391,425,444,462,519,604],"individual":[69],"antigens,":[70],"AND-gated":[71,94,334,383],"TCEs":[72],"impart":[74],"anti-tumor":[75],"efficacy":[76],"reduced":[78],"toxicity.":[79],"Here,":[80],"we":[81,127],"aimed":[82],"and":[85,121,172,189,226,236,238,270,288,302,314,353,373,413,423,443,464,478,493,515,587,600],"validate":[86],"a":[87,92,247,327,563,577],"tumor-specific":[88,160,329],"pair":[90,233,352],"potential":[93,328],"TCE.Methods":[95],"Gene":[96,140],"signatures":[97],"were":[98,147,197,216,257,276],"used":[99],"in":[104,209,234,259,331,360,385,403,446,481,518,534,603,622,670],"publicly":[105],"available":[106],"single":[107,565,580],"RNA-sequencing":[109],"(scRNA-seq)":[110],"datasets":[111],"colorectal":[113,405,430],"(CRC),":[114],"1":[115],"2":[116],"non-small":[117,448],"lung":[119,450,469,482],"(NSCLC),3\u20135":[120],"breast":[122,499],"cancer":[123,358,387,483,535],"(BC).6":[124],"7":[125],"Next,":[126],"compiled":[128],"genes":[129],"predicted":[130],"encode":[132],"cell-surface":[133],"proteins.8":[134],"find":[136],"genes,":[138],"Weighted":[139],"Correlation":[141],"Network":[142],"Analysis":[143],"(WGCNA)":[144],"was":[145,164,220],"applied.9":[146],"then":[148],"analyzed":[149],"using":[154],"published":[155],"scRNA-seq":[156,392],"data.10\u201312":[157],"For":[158],"one":[159,212],"pair,":[161],"membrane":[162],"co-expression":[163],"examined":[165],"via":[166],"multiplex":[167],"immunohistochemistry":[168],"(IHC)":[169],"tissue-derived":[174],"microarrays":[175],"(TMAs).":[176],"In":[177],"addition,":[178],"five":[179,190],"adenocarcinoma":[180,300],"CRC":[181,194,235,269,287,304],"blocks":[183,196,298],"known":[185,239],"mesothelin":[186,669],"(MSLN)":[187],"unbiasedly":[191],"chosen":[192],"mucinous":[193,303],"also":[198],"assessed.Results":[199],"From":[200],"66":[201],"identified":[206],"by":[207],"WGCNA":[208],"more":[210],"than":[211],"dataset,":[213],"only":[214],"three":[215],"tumor-specific.":[217],"Target":[218],"validation":[219,375],"pursued":[221],"mucin":[223],"13":[224],"(MUC13)":[225],"MSLN,":[227],"due":[228],"NSCLC":[237,274,292],"toxicities":[240,339],"therapies":[242,384],"MSLN.":[244],"12\u201315":[245],"On":[246,263],"TMA,":[249],"dual-positive":[253,357],"staining":[254],"MUC13xMSLN":[256,325,335],"observed":[258],"3":[260],"non-essential":[261],"tissues.":[262],"tumor-derived":[264],"TMAs,":[265],"37%":[266],"(11/30)":[267],"0%":[271],"(0/30)":[272],"samples":[275],"double-positive,":[277],"consistent":[278],"bioinformatics":[281,372],"data":[282,368],"where":[283],"18%":[284],"(10/55)":[285],"4%":[289],"(2/50)":[290],"patients":[293,348,362],"showed":[294,306],"co-expression.":[295],"Double-positive":[296],"(4/5)":[301],"(3/5)":[305],"respective":[307],"fractions":[308],"double-positive":[310],"1-15%":[313],"1-50%.Conclusions":[315],"our":[317],"knowledge,":[318],"this":[319,367],"first":[322],"report":[323],"as":[326],"antigen-pair":[330],"CRC.":[332],"An":[333],"TCE":[336],"reduce":[338],"seen":[340],"MSLN":[342],"therapies,":[343],"although":[344],"percentage":[346],"frequency":[355],"these":[361],"relatively":[364],"low.":[365],"Overall,":[366],"suggests":[369],"described":[371],"protein":[374],"approach":[376],"suitable":[378],"identifying":[380],"targets":[381],"other":[386],"subtypes.Acknowledgements":[388],"Excelra":[389],"conducted":[390],"analysisReferences":[393],"Pelka":[394],"K,":[395],"et":[396,410,436,456,474,489,505,526,574,593,612,635,654],"al.":[397,411,437,457,475,490,506,527,575,594,613,636,655],"Spatially":[398],"organized":[399],"multicellular":[400],"immune":[401],"hubs":[402],"human":[404,498,520,605],"cancer.":[406,431,451],"Cell.":[407],"2021;184(18):4734\u20134752.e20.Joanito":[408],"I,":[409],"Single-cell":[412,438,458],"bulk":[414],"transcriptome":[415],"sequencing":[416,460],"identifies":[417],"two":[418],"epithelial":[419],"states":[422,517,602],"refines":[424],"consensus":[426],"molecular":[427,463],"classification":[428],"Nat":[432,452,471,485,501,608,631],"Genet.":[433,502],"2022;54:963\u2013975.Wu":[434],"F,":[435],"profiling":[439],"heterogeneity":[442],"microenvironment":[445],"advanced":[447],"Commun.":[453,472],"2021;12:2540.Kim":[454],"N,":[455,573],"RNA":[459,509],"demonstrates":[461],"cellular":[465],"reprogramming":[466],"metastatic":[468],"adenocarcinoma.":[470],"2020;11:2285.Laughney":[473],"Regenerative":[476],"lineages":[477],"immune-mediated":[479],"pruning":[480],"metastasis.":[484],"Med.":[486,632],"2020;26(2):259\u2013269.Wu":[487],"S,":[488],"A":[491,507],"single-cell":[492,508,596],"spatially":[494],"resolved":[495],"atlas":[496,511,568,583],"cancers.":[500,672],"2021;53(9):1334\u20131347.Pal":[503],"B,":[504,592],"normal,":[513],"preneoplastic":[514],"tumorigenic":[516],"breast.":[521],"EMBO":[522],"J.":[523],"2021;40(11):e107333Dannenfelser":[524],"R,":[525,611],"Discriminatory":[528],"power":[529],"combinatorial":[531],"recognition":[533],"therapies.":[538],"Cell":[539],"Syst.":[540],"2020;11(3):215\u2013228.e5.Langfelder":[541],"P,":[542],"Horvath":[543],"S.":[544],"WGCNA:":[545],"an":[546],"R":[547],"package":[548],"weighted":[550],"correlation":[551],"network":[552],"analysis.":[553],"BMC":[554],"Bioinform.":[555],"2008;9:559.The":[556],"Tabula":[557],"Sapiens":[558],"Consortium.":[559],"The":[560],"tabula":[561],"sapiens:":[562],"multiple-organ,":[564],"transcriptomic":[567],"humans.":[570],"Science.":[571],"2022;376:eabl4896.Lee":[572],"Establishing":[576],"bone":[578],"marrow":[579],"reference":[582],"study":[585,658],"ageing":[586],"diseases.":[588],"Front.":[589],"Immunol.":[590],"2023;14:1127879.Lake":[591],"Integrative":[595],"analysis":[597],"transcriptional":[599],"epigenetic":[601],"adult":[606],"brain.":[607],"Biotechnol.":[609],"2018;36(1):70\u201380.Hassan":[610],"Mesothelin-targeting":[614],"receptor":[617],"fusion":[618],"construct":[619],"therapy":[621],"refractory":[623],"solid":[624],"tumors:":[625],"phase":[626],"1/2":[627],"trial":[628],"interim":[629],"results.":[630],"2023;29(8):2099\u20132109.Haas":[633],"A,":[634],"Two":[637],"cases":[638],"severe":[640],"pulmonary":[641],"toxicity":[642],"from":[643],"highly":[644],"active":[645],"mesothelin-directed":[646],"CAR":[647],"Mol":[650],"Ther.":[651],"2023;31(8):2309\u20132325.Tanyi":[652],"J,":[653],"Phase":[656],"I":[657],"autologous":[660],"bearing":[663],"fully-humanized":[664],"chimeric":[665],"receptors":[667],"mesothelin-expressing":[671],"Gynecol":[673],"Oncol.":[674],"2022;166:S164-S165.":[675]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2025-11-05T00:00:00"}